174 related articles for article (PubMed ID: 1431591)
1. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.
McConathy WJ; Gesquiere JC; Bass H; Tartar A; Fruchart JC; Wang CS
J Lipid Res; 1992 Jul; 33(7):995-1003. PubMed ID: 1431591
[TBL] [Abstract][Full Text] [Related]
2. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang CS; McConathy WJ; Kloer HU; Alaupovic P
J Clin Invest; 1985 Feb; 75(2):384-90. PubMed ID: 3973011
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
[TBL] [Abstract][Full Text] [Related]
4. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
[TBL] [Abstract][Full Text] [Related]
6. Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase.
McIlhargey TL; Yang Y; Wong H; Hill JS
J Biol Chem; 2003 Jun; 278(25):23027-35. PubMed ID: 12682050
[TBL] [Abstract][Full Text] [Related]
7. Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles.
Lambert DA; Catapano AL; Smith LC; Sparrow JT; Gotto AM
Atherosclerosis; 1996 Dec; 127(2):205-12. PubMed ID: 9125310
[TBL] [Abstract][Full Text] [Related]
8. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
[TBL] [Abstract][Full Text] [Related]
9. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
10. Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation.
Silbernagel G; Chen YQ; Rief M; Kleber ME; Hoffmann MM; Stojakovic T; Stang A; Sarzynski MA; Bouchard C; März W; Qian YW; Scharnagl H; Konrad RJ
Eur Heart J; 2023 Jul; 44(25):2335-2345. PubMed ID: 37155355
[TBL] [Abstract][Full Text] [Related]
11. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
Liu H; Talmud PJ; Lins L; Brasseur R; Olivecrona G; Peelman F; Vandekerckhove J; Rosseneu M; Labeur C
Biochemistry; 2000 Aug; 39(31):9201-12. PubMed ID: 10924113
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
[TBL] [Abstract][Full Text] [Related]
13. Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II.
Kinnunen PK; Jackson RL; Smith LC; Gotto AM; Sparrow JT
Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4848-51. PubMed ID: 270715
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.
Liu H; Labeur C; Xu CF; Ferrell R; Lins L; Brasseur R; Rosseneu M; Weiss KM; Humphries SE; Talmud PJ
J Lipid Res; 2000 Nov; 41(11):1760-71. PubMed ID: 11060345
[TBL] [Abstract][Full Text] [Related]
15. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
16. Activation of lipoprotein lipase by apolipoprotein C-II is modulated by the COOH terminal region of apolipoprotein C-III.
Catapano AL
Chem Phys Lipids; 1987 Oct; 45(1):39-47. PubMed ID: 3446410
[TBL] [Abstract][Full Text] [Related]
17. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL.
Berbée JF; van der Hoogt CC; Sundararaman D; Havekes LM; Rensen PC
J Lipid Res; 2005 Feb; 46(2):297-306. PubMed ID: 15576844
[TBL] [Abstract][Full Text] [Related]
18. Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by hjman apolipoprotein C-II.
Fitzharris TJ; Quinn DM; Goh EH; Johnson JD; Kashyap ML; Srivastava LS; Jackson RL; Harmony JA
J Lipid Res; 1981 Aug; 22(6):921-33. PubMed ID: 7276752
[TBL] [Abstract][Full Text] [Related]
19. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
